Envestnet Asset Management
FLNA

Envestnet Asset Management’s Filana Therapeutics FLNA Stock Holding History

Envestnet Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,887
Closed -$291K – 4383
2024
Q3 		$291K Buy
+9,887
New +$228K ﹤0.01% 3842
2023
Q1 		– Sell
-7,721
Closed -$228K – 4091
2022
Q4 		$228K Buy
7,721
+875
+13% +$31.4K ﹤0.01% 3605
2022
Q3 		$286K Sell
6,846
-2,872
-30% -$77.6K ﹤0.01% 3379
2022
Q2 		$273K Buy
9,718
+2,981
+44% +$75.3K ﹤0.01% 3409
2022
Q1 		$250K Buy
6,737
+1,736
+35% +$73.6K ﹤0.01% 3558
2021
Q4 		$219K Buy
+5,001
New +$262K ﹤0.01% 3605
2020
Q1 		– Sell
-48,589
Closed -$253K – 3117
2019
Q4 		$253K Sell
48,589
-4,700
-9% -$8.11K ﹤0.01% 2811
2019
Q3 		$64K Sell
53,289
-9,603
-15% -$12.3K ﹤0.01% 2978
2019
Q2 		$76K Buy
62,892
+12,104
+24% +$13.7K ﹤0.01% 2971
2019
Q1 		$66K Sell
50,788
-2,777
-5% -$3.19K ﹤0.01% 2915
2018
Q4 		$46K Buy
+53,565
New +$61.6K ﹤0.01% 2809

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Envestnet Asset Management's FLNA Position: Q4 2024 in Review

Envestnet Asset Management sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 9,887 shares — an estimated $291K sold.

Envestnet Asset Management first reported a position in FLNA in Q4 2018 and held it in 11 quarters. The position peaked at $291K in Q3 2024. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Envestnet Asset Management reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 9,887 Filana Therapeutics shares in Q4 2024, an estimated $291K.
  • Envestnet Asset Management first reported a position in Filana Therapeutics in Q4 2018 and held it in 11 quarters.
  • Envestnet Asset Management's Filana Therapeutics position peaked at $291K in Q3 2024.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Envestnet Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.